Combination therapy in type 2 diabetes mellitus: Adding empagliflozin to basal insulin

Andrew Ahmann

Research output: Contribution to journalComment/debatepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Combination therapy in type 2 diabetes mellitus: Adding empagliflozin to basal insulin'. Together they form a unique fingerprint.

Medicine & Life Sciences